In immunodeficient NSG (severely combined immunodeficient (NOD/SCID) interleukin-2 receptor (IL-2R) gamma chain null) mice, anti-PD-1 antibody had no effect on tumor growth in either control or B16F10 cells with FTO knockdown (Fig. 8b). This evidence concerns the gene PDCD1 and neoplasm.